It's important to note that Epithalon works at the cellular level, so benefits may be subtle initially but compound over time with consistent treatment cycles
[DOI] [PMC free article] [PubMed] [Google Scholar] 248.Dalle Carbonare L, Valenti MT, Del Forno F, Caneva E, Pietrobelli A
Bioactive compounds in oxidative stress-mediated diseases: targeting the NRF2/ARE signaling pathway and epigenetic regulation
Importantly, circulating HTY metabolites, mainly HTY sulfate and HTY glucuronides, reach plasma concentrations several-fold higher than parent HTY and retain cardiovascular-related bioactivity
In 1998, Cephalon, the pharmaceutical company that manufactures it, received government approval to market the drug, but only for excessive daytime sleepiness due to narcolepsy